Publication:
Pharmacotherapy for older people with obesity

Simple item page
dc.contributor.coauthorBoyle, Luke D.
dc.contributor.coauthorAkbas, Feray
dc.contributor.coauthorMcGowan, Barbara M.
dc.contributor.coauthorYumuk, Volkan
dc.contributor.kuauthorDereli, Dilek Yazıcı
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.date.accessioned2024-12-29T09:37:21Z
dc.date.issued2024
dc.description.abstractRates of obesity continue to rise, including in older adults. Use of medication for obesity in the elderly has been considered controversial, due to concerns around potential progression of age-related sarcopenia and a general lack of evidence for its use in this age group. Within this review, we describe the general considerations when prescribing obesity pharmacotherapy for older adults living with obesity. We evaluate in detail the anti-obesity medications currently licenced in Europe, with emphasis on the available efficacy, safety and cardiovascular outcome data gathered from study of older people. Finally, we discuss future directions and avenues of research. © 2024
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.publisherscopeInternational
dc.description.volume130
dc.identifier.doi10.1016/j.ejim.2024.05.006
dc.identifier.eissn1879-0828
dc.identifier.issn0953-6205
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85196375984
dc.identifier.urihttps://doi.org/10.1016/j.ejim.2024.05.006
dc.identifier.urihttps://hdl.handle.net/20.500.14288/22339
dc.keywordsElderly
dc.keywordsObesity
dc.keywordsOlder people
dc.keywordsPharmacotherapy
dc.keywordsSarcopenia
dc.languageen
dc.publisherElsevier B.V.
dc.sourceEuropean Journal of Internal Medicine
dc.subjectBody mass
dc.subjectObesity
dc.subjectCohort study
dc.titlePharmacotherapy for older people with obesity
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorDereli, Dilek Yazıcı

Files

Collections

Publications without Fulltext